BioCorRx Inc.

BICX OTC SEC CIK 1443863
Follow BioCorRx Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$797.1K +5.9% vs same quarter last year
EPS, diluted −$0.03 +40% vs same quarter last year
Operating cash flow −$179.6K +69.2% vs same quarter last year
Operating income −$1.4M +20.8% vs same quarter last year
Revenue by quarter
$0
$134.9K
$178.2K
$213.9K
$270.2K
$214.5K
$88K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$797.2K−$3.4M
FY24$7.7K−$5.1M
FY23$89.2K−$3.8M
FY22$213.8K−$4.4M
FY21$48.3K−$5.2M
FY20$122.6K−$3.5M
FY19$240.3K−$6M
FY18$376.7K−$6.6M
FY17$657.3K−$29.7M
FY16$701.8K−$5.9M
FY15$924.7K−$4.7M
FY14$1.2M−$3.1M
FY13$715K−$3.8M
FY12$868.2K−$885.8K
FY11$771.8K−$409K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−80000%−60000%−40000%−20000%0%20000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−606%−431.5%
FY2478.3%−66829.8%−66616.1%
FY2359.6%−4248.3%−4228.9%
FY2292.9%−2197%−2046.8%
FY2187.8%−11414.7%−10794.3%
FY2021.8%−6109.9%−2859.6%
FY1966%−2314.7%−2517.4%
FY1854.6%−1228.2%−1748.1%
FY1750.8%−439.8%−4519.5%
FY1675%−310.9%−841.3%
FY1583.6%−553.4%−504.6%
FY1481.1%−260.7%−267.1%
FY1377.6%-−536.9%
FY1253.6%-−102%
FY1148.1%-−53%
Free cash flowOperating cash flow minus capital expenditure
−$4M−$3M−$2M−$1M$0$1MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22−$2M
FY21−$3.5M
FY20−$2.2M
FY19−$3.1M
FY18−$1.8M
FY17−$2.5M
FY16−$2.3M
FY15-
FY14$167.2K
FY13$96.8K
FY12−$928.6K
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • BioCorRx
  • Healthcare median
−80000%−60000%−40000%−20000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBioCorRxHealthcare median
FY25−431.5%−30.6%
FY24−66616.1%−47%
FY23−4228.9%−58%
FY22−2046.8%−80.4%
FY21−10794.3%−71.8%
FY20−2859.6%−62.2%
FY19−2517.4%−46.2%
FY18−1748.1%−49.6%
FY17−4519.5%−45.9%
FY16−841.3%−36%
FY15−504.6%−37.8%
FY14−267.1%−35.5%
FY13−536.9%−37.1%
FY12−102%−29.1%
FY11−53%−27.9%